惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

小众软件
小众软件
C
Check Point Blog
Vercel News
Vercel News
Y
Y Combinator Blog
G
Google Developers Blog
P
Proofpoint News Feed
WordPress大学
WordPress大学
MongoDB | Blog
MongoDB | Blog
博客园 - 司徒正美
Last Week in AI
Last Week in AI
博客园 - 【当耐特】
N
Netflix TechBlog - Medium
L
LangChain Blog
V
V2EX
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
大猫的无限游戏
大猫的无限游戏
D
DataBreaches.Net
博客园_首页
B
Blog RSS Feed
The Cloudflare Blog
MyScale Blog
MyScale Blog
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
Microsoft Security Blog
Microsoft Security Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Accendra Health, Inc. (ACH) Q1 2026 Earnings Call Transcript
2026-05-12 · via All Articles on Seeking Alpha

Accendra Health, Inc. (ACH) Q1 2026 Earnings Call May 11, 2026 8:30 AM EDT

Company Participants

Will Parrish
Edward Pesicka - President, CEO & Director
Jonathan Leon - Executive VP, CFO & Corporate Treasurer
Perry Bernocchi - Executive VP & COO

Conference Call Participants

Kevin Caliendo - UBS Investment Bank, Research Division
Daniel Grosslight - Citigroup Inc., Research Division
Ahmed Muhammad Rahat - Leerink Partners LLC, Research Division
Allen Lutz - BofA Securities, Research Division

Presentation

Operator

Hello. Good morning, and thank you for standing by. Welcome to the Accendra Health's First Quarter 2026 Earnings Conference Call. Please be advised that today's conference call is being recorded. [Operator Instructions] I would now like to hand the conference over to your first speaker today, Will Parrish, Vice President, Strategy, Corporate Development and Investor Relations. Please go ahead.

Will Parrish

Thank you, operator, and good morning, everyone. I'd like to welcome you to Accendra Health's First Quarter Earnings Call. Our comments on the call will be focused on the financial results of the first quarter of 2026, all of which are included in today's press release. The press release, along with the first quarter 2026 supplemental slides, which we will refer to throughout the call are posted in the Investor Relations section of our website.

Please note that during the call, we will make forward-looking statements that reflect the current views of Accendra Health about our business, financial performance and future events. Matters addressed in these statements are subject to risks and uncertainties, which could cause actual results to differ materially from those projected or implied here today.

Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that our expectations, beliefs and projections will result or be achieved. Please refer to our SEC